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Abstract
Mesenchymal stem cells (MSCs) derived from adult tissues are an important candidate for cell-based therapies and
regenerative medicine due to their multipotential differentiation capability. MSCs have been identified in many adult tissues
but have not reported in the human intervertebral disc cartilage endplate (CEP). The initial purpose of this study was to
determine whether MSCs exist in the degenerated human CEP. Next, the morphology, proliferation capacity, cell cycle, cell
surface epitope profile and differentiation capacity of these CEP-derived stem cells (CESCs) were compared with bone-
marrow MSCs (BM-MSCs). Lastly, whether CESCs are a suitable candidate for BM-MSCs was evaluated. Isolated cells from
degenerated human CEP were seeded in an agarose suspension culture system to screen the proliferative cell clusters. Cell
clusters were chosen and expanded in vitro and were compared with BM-MSCs derived from the same patient. The
morphology, proliferation rate, cell cycle, immunophenotype and stem cell gene expression of the CESCs were similar to
BM-MSCs. In addition, the CESCs could be induced into osteoblasts, adipocytes, chondrocytes, and are superior to BM-MSCs
in terms of osteogenesis and chondrogenesis. This study is first to demonstrate the presence of stem cells in the human
degenerated CEP. These results may improve our understanding of intervertebral disc (IVD) pathophysiology and the
degeneration process, and could provide cell candidates for cell-based regenerative medicine and tissue engineering.
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Introduction
Low back pain is one of the most common reasons for seeking
medical advice and is a major cause of work-related disabilities
[1]. The most common cause of low back pain is degenerative
disc disease (DDD) [2]. Many factors have been believed to
influence the intervertebral disc (IVD) degeneration, including
mechanical loading [3] and hereditary factors [4]. A possible role
of the intervertebral cartilage endplate (CEP) has also been
pointed out [5]. The CEP is a thin layer of hyaline cartilage that
separates the vertebral bone from the disc and prevents the
nucleus pulposus (NP) from bulging into the adjacent vertebrae.
Changes in biochemical composition within the CEP are related
closely to DDD. Proteoglycan molecules are critical for the
control of solute transport through the disc, and the depletion of
proteoglycans from the CEP is associated with loss of proteogly-
cans from the NP [6]. Thus, proteoglycan loss within the CEP
will ultimately lead to DDD [7]. The disc is regarded as the
largest avascular structure in the body, and mature discs are
almost totally reliant on the diffusion of nutrient solutes across the
CEP for metabolic exchange [8]. Calcification of the CEP or
sclerosis decreases the permeability of glucose, oxygen, and other
amino acids into the disc, and this finally lead to DDD [9,10].
However, the onset of CEP calcification is not well understood
[11,12]. Apoptosis of chondrocytes within the CEP is another
main cause of DDD [13]. According to some authors, CEP
degeneration plays a crucial role in the initiation and develop-
ment of DDD [14]. Therefore, studies of cell composition and
bionomical characteristics are crucial to clarify the mechanisms of
CEP degeneration and DDD.
Current treatment modalities for DDD are mainly focused on
providing symptomatic relief by the removal of disc tissue without
treating the underlying cause or restoring mechanical function.
Therefore, therapies that both alleviate painful symptoms and
restore disc structure and mechanical function by directly
addressing the underlying biological causes of disc degeneration
are needed [15]. Recently, cell-based therapies for regenerating or
repairing the disc have become treatment options [15,16].
Therapies based on mesenchymal stem cells (MSCs), such as
tissue engineering, have gained much public interest. Human bone
marrow MSCs (BM-MSCs), which were firstly isolated in 1999 by
Pittinger, are easy to collect and are considered to be a promising
cell source for various tissue repair and regeneration [17]. In
addition, a number of adult tissues (adipose, muscle, tendon,
synovial membrane, skin, IVD, and periosteum) contain popula-
tions of stem cells [18–20]. All of these MSCs share similar
characteristics, such as propagation in culture for many genera-
tions, self-renewal ability, and capacity for multilineage differen-
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cell-based treatment of DDD.
Current cell-based therapies mainly target NP degeneration, but
calcification of the CEP may block nutrient supply to the
implanted cells and finally affect the cell activity [11,12].
Therefore, the state of CEP plays an important role for the
success of cell-based therapies. Stimulating the in situ cells within
the degenerated CEP to proliferate and synthesize the matrix may
be an ideal approach to prevent its degeneration and to maintain
the activity of the implanted cells. Studies to clarify the cell
characteristics of degenerated CEP and to determine whether stem
cells exist within this tissue are meaningful.
In the present study, we isolated stem cells from degenerated
human CEP harvested through posterior discectomy procedure
for the lumber degenerative disease, and compared them with
BM-MSCs obtained from the same patient. Both types of cells had
similar morphology, proliferation rate, cell cycle, immunopheno-
type, and stem cell gene expression. CESCs could be induced into
osteoblasts, adipocytes, and chondrocytes, and they are superior in
terms of osteogenesis and chondrogenesis. These data indicate that
CESCs may be a potential candidate for cell-based regenerative
medicine and tissue engineering.
Materials and Methods
Ethics Statement
Institutional Review Board approval and informed consent for
sample collection were obtained before collection of all samples.
All the procedures specified below were approved by the Ethical
Committee of Xinqiao Hospital and were in accordance with the
Helsinki Declaration.
Case Selection
The CEP used in this study was obtained from 7 patients who
underwent the posterior discectomy procedure for the lumbar
degenerative disease. During the surgical procedure, 5–10 ml
bone marrow (BM) was obtained by iliac crest aspiration from the
same patient. The average age was 42.1 years (range: 36–50 years),
and the male/female ratio was 3/4. Details of all samples were
shown in Table 1.
Isolation and Culture of Human BM-MSCs
BM-MSCs were isolated as previously described [21]. Briefly,
5–10 ml of BM aspirate was collected in a syringe contain-
ing 10,000 IU of heparin to prevent coagulation. Low-density
mononuclear cells were isolated by centrifugation through
1.073 g/ml of Percoll solution (Sigma, USA) at 10006g for
30 minutes. The cells were rinsed twice with phosphate buffered
saline (PBS) and resuspended in Dulbecco’s modified Eagle’s
medium/F12 (DMEM/F12, HyClone, USA) supplemented with
10% fetal calf serum (FCS, HyClone, USA) and 100 U/ml
penicillin-streptomycin (HyClone, USA). All of the nucleated cells
were cultured in a 25-cm
2 cell culture flask (Costar Corning, USA)
in a humidified atmosphere containing 5% CO2 at 37uC. After
24 hours, the nonadherent cells were removed by replacing the
medium, and the adherent cells were washed twice with PBS and
cultured with above culture medium. After reaching 90%
confluence, the cells were harvested with 0.25% trypsin and
1 mM EDTA (trypsin/EDTA, HyClone, USA) for 3 minutes at
37uC, and subcultured at a dilution of 1:3. Passage 3 cells were
used in the study.
Isolation and Culture of Degenerated Human CEP-
derived Cells
Surgically explanted CEP was cleaned of any adherent
extraneous invasive tissue under the sterilized dissecting micro-
scope (Leica, Germany).Briefly, remove the NP, annulus fibro-
sus and subchondral bone tissues around blocks of CEP
using ophthalmic operating set under dissecting microscope (46
magnification). The average thickness of CEP blocks was 0.8 mm.
After washing with PBS, a small tissue (from each donator) was
used for hematoxylin and eosin staining (HE) to rule out whether
any other tissues were also present in the CEP. The remaining
sample was minced into pieces no larger than 1 mm
3 and digested
with 0.15% collagenase II [Sigma, USA] in DMEM/F12
containing 3% FCS for 12 hours at 37uC. At the end of the
digestion, the suspended cells were filtered through a 70-mm cell
filter to minimize cell aggregates. The cell suspension was
transferred to a sterile conical tube and centrifuged for 10 minutes
at 2006g. After aspirating the supernatant, the pellet was
resuspended in DMEM/F12 supplemented with 10% FCS and
5 units/ml penicillin and streptomycin. Total cell number per
tissue sample was 2.5610
5 to 7.5610
5. Then the cells were
cultured in 25-cm
2 cell culture flask in a humidified atmosphere
containing 5% CO2 at 37uC. After the first passage of expansion,
cells were sub-cultured in agarose suspensions.
Agarose Cultures to Select CESCs
The agarose culture was established using the protocol
published by Thornemo in 2005 [22]. Briefly, 2% low-melting
point agarose (Invitrogen, USA) was sterilized by autoclaving
andthen equilibrated to 37uC before the next procedure. Culture
dishes (60 mm in diameter, Costar Corning, USA) were coated
with 1% low-melting point agarose which was mixed with an equal
Table 1. Details of the patients enrolled in this study.
Case No. Diagnosis Disc Level Modic Type
BM
(ml) Gender
Age
(year)
1 Spondylolisthesis L4-L5 II 7.0 M 40
2 Spondylolisthesis L4-L5 I 6.5 F 39
3 Spondylolisthesis L5-S1 II 10.0 M 36
4 Spinal stenosis L5-S1 II 5.0 F 50
5 Vertebral instability L4-L5 II 7.5 F 43
6 Discogenic low back pain L5-S1 II 6.5 M 46
7 Discogenic low back pain L4-L5 I 8.5 F 41
doi:10.1371/journal.pone.0026285.t001
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agarose and the excess agarose was removed by aspiration.-
Subsequently, a mixture of 0.75 ml of DMEM/F12, 0.75 ml of
2% low-melting point agarose and 1.5 ml of 20% FCS DMEM/
F12 containing 5610
4 P1 CEP-derived cells was added to the
culture dishes. The final concentration of FCS was 10%.
C u l t u r ed i s h e sw e r eh e l da t4 uCf o r1 5m i n u t e su n t i lt h eg e l s
solidified. The culture dishes were then incubated in a
humidified atmosphere containing 5% CO2 at 37uC. Change
culture medium with DMEM/F12 supplemented with 10% FCS
and 5 units/ml penicillin and streptomycin twice a week. After 6
weeks, cell clusters (diameter greater than 50 mm) were isolated
using a sterile Pasteur pipette and subcultured in multi-well
plates (Costar Corning, USA). Passage 3 CESCs were used in
the study.
Measurement of Cell Proliferation Capacity
To measure the proliferation capacity of the CESCs and BM-
MSCs, Cell Counting Kit-8 (CCK-8, Dojindo Laboratories,
Japan) was used as previously described [23]. Briefly, 10 mLo f
CCK-8 solution was added to each well which contained 3000
cells. After incubating the 96-well plate at 37uC for 4 hours, the
absorbance at 450 nm was measured using a microplate
absorbance reader (BioRad, USA). Cell proliferation was tested
on days 1, 3, 5, 7 and 9. The blank 96-well plate was used for the
zero setting. All experiments were performed in triplicate.
Figure 1. Histomorphology of degenerated human CEP tissues. A. gross morphology. B. histologic morphology with HE staining.
Bar=50 mm.
doi:10.1371/journal.pone.0026285.g001
Table 2. Primers used for RT-PCR and qPCR analysis.
Target Gene Primers Sequence TA(6C) Cycles
RUNX-2 sense 59-ACGACAACCGCACCATGGT-39
antisense 59-CTGTAATCTGACTCTGTCCT-39
59 30
alkaline phosphatase (ALP) sense 59-TGGAGCTTCAGA AGCTCAACACCA-39
antisense 59-ATCTCGTTGTCTGAGTACCAGTCC-39
59 28
osteocalcin (OC) sense 59-ATGAGAGCCCTCACACTCCTC-39
antisense 59-GCCGTAGAAGCGCCGATAGGC-39
59 30
peroxisome proliferators-activated
receptor 2 (PPAR-2)
sense 59-CGAGGGCGATCTTGACAGGAA -39
antisense 59-CAGGGGGGTGATGTGTTTGAAC- 39
55 30
adipogenic protein (APP) sense 59-CTGTCCAAGTCCAACAGCAA-39
antisense 59-ACGTTGGCAGCTTTACGTCT-39
55 30
lipoprotein lipase (LPL) sense 59-TCCGCGTGATTGCAGAGAGAG-39
antisense 59-TGCTGCTTCTTTTGGCTCTGACT-39
55 30
aggrecan (Agg) sense 59-TGAGGAGGGCTGGAACAAGTACC-39
antisense 59-GGAGGTGGTAATTGCAGGGAACA-39
57 28
collagen II (Col II) sense 59-TTTCCCAGGTCAAGATGGTC-39
antisense 59-TCACCTGGTTTTCCACCTTC-39
57 30
SOX-9 sense 59-TGGCCGAGATGATCCTAAAAATAA -39
antisense 59-GCGCTTGGATAGGTCATGTTTGT-39
57 30
SOX-2 sense 59-CCCCTGTGGTTACCTCTTCCTC-39
antisense 59-GGCCGCTCTGGTAGTGCTG-39
61 32
NANOG sense 59-ACCCCGTTTCACTGTGTTAGC-39
antisense 59-GACGGCAGCCAAGGTTATTAAA-39
63 32
OCT4 sense 59-GGCAAGCGATCAAGCAGCGAC-39
antisense 59-GGGAAAGGGACCGAGGAGTAC-39
61 32
b-actin sense 59-GTGGGGCGCCCCAGGCACCA-39
antisense 59-CTTCCTTAATGTCACGCACGATTTC-39
55 45
doi:10.1371/journal.pone.0026285.t002
Stem Cells in Degenerated Human Cartilage Endplate
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26285Cell Cycle Assay
For the cell cycle analysis, both CESCs and BM-MSCs were
fixed with 75% cold ethanol for 72 hours at 4uC. After washed
with PBS two times, 1 ml propidium iodide (PI, Invitrogen, USA)
staining solution and 50 mL RNase A stock solution (Invitrogen,
USA) were added and incubated at 4uC for 3 hours. Measure-
ments were performed on a FACSCalibur flow cytometer (BD,
USA) by using CellQuest software (BD, USA) and acquiring
$20,000 cells per sample.
Determination of the Cell-surface Antigen Profile
For the immunophenotypic characterization of BM-MSCs and
CESCs, cells were washed with PBS and incubated with the
following fluorescein isothiocyanate (FITC)-, phycoerythrin (PE)-,
peridinin chlorophyll protein (PerCP)-, allophycocyanin (APC)-
coupled monoclonal antibodies: CD14-FITC, CD19-APC, CD34-
FITC, CD45-FITC, CD44-PE, CD73-FITC, CD90-FITC,
CD105-PE, CD133-FITC, CD166-FITC, HLA-DR-PerCP and
STRO1-FITC. All antibodies were purchased from eBioscience
(USA), except for STRO1-FITC (Santa Cruz Biotechnology,
USA). Isotype control antibodies were used in each case. After
incubating for 30 minutes at 37uC, cells were washed 3 times with
PBS. Finally, labelled cells were re-suspended in 500 ml PBS and
subjected to single channel flow cytometry analysis (BD, USA). At
least 10
4 events were collected per sample. The extent of positive
staining was calculated as a percentage in comparison with the
isotype staining.
Stem Cell Gene Expression Assay
To evaluate the expression of the genes responsible for stem
cells, three stem cell genes (NANOG, SOX-2 and OCT-4) were
analyzed using the reverse transcriptase polymerase chain reaction
(RT-PCR). Details of the related genes were listed in Table 2, and
the procedure was depicted below.
Differentiation Procedures and Related Quantitative
Assays
For the in vitro differentiation assays, three procedures were
used.
(1). Osteogenic Induction. The cells were incubated in an
osteogenic medium containing 10% FCS, 10 nM dexamethasone,
10 mM b-glycerophosphate, and 0.1 mM L-ascorbic acid-2-
phosphate for 3 weeks. The medium was changed twice a week.
Negative control wells were maintained in DMEM/F12
supplemented with 10% FCS.
Quantitative Assay of Mineral Deposits
1.5610
4 cells were seeded in each well of a 24-well plate. The
cells were incubated in the osteogenic medium for 1, 2, 3 or 4
weeks. After each induction time, the cells were washed with PBS
and fixed in 70% ethanol for 1 hour at room temperature. Then
the cells were stained with 40 mM/L alizarin red (ph 4.2) for
10 minutes at room temperature. After washing with distilled
water 5 times, the cells were incubated with PBS at 37uC for
15 minutes. Finally, the cells were incubated with 300 ml 10%
CPC (cetylyridinium chloride) at 37uC for an additional
15 minutes and the optical density of the extracted dye was
evaluated at 562 nm in a spectrophotometer.
Quantitative Assay of Alkaline Phosphatase (ALP) Activity
To quantify ALP activity, a modified procedure was used as
described previously [24]. Briefly, 1.5610
4 cells of the BM-
MSCs and CESCs were seeded in each well of a 24-well plate,
and incubated in the osteogenic medium for 1, 2, 3 or 4 weeks.
After each induction time, the cells were washed with PBS
and incubated in 400 ml lysed solution with 10 mM Tris-HCl
containing 1 mM MgCl2 and 1% Triton X-100 at 4uC.
Subsequently, 50 ml (6.7 mM/L) fresh freezing p-nitrophenyl
phosphate (pNPP) was used as the substrate to measure ALP
activity based on p-nitrophenol (pNP) release. The substrate
a n dt h el y s e ds o l u t i o nw e r ei n c u b a t e da t3 7 uC for 2 hours.
Finally, the reaction was stopped by the addition of 100 ml
0.1 M NaOH and was monitored at 405 nm. The optical
Figure 2. Morphology of cells derived from CEP and BM.
Morphology of CEP-derived cells in agarose after immediately seeded
(A) and six weeks later (B). Morphology of BM-MSCs (C) and CESCs (D).
Bar=100 mm.
doi:10.1371/journal.pone.0026285.g002
Figure 3. The proliferation capacity of BM-MSCs and CESCs
measured using the CCK-8 assay. The OD values were not
significantly different between the BM-MSCs and CESCs on day 1, 3,
5, 7 or 9, suggesting that the proliferation capacity of the two cell types
were the same. Data from cells derived from 7 different patients (mean
6 SD).
doi:10.1371/journal.pone.0026285.g003
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spectrophotometer.
(2). Adipogenic Induction. Adipogenic differentiation was
performed in cultures with induction and maintenance medium.
Briefly, these cells were exposed to an induction medium
containing 10 mg/ml insulin, 1 mM dexamethasone, 500 mM3 -
isobutyl-1-methyl xanthine, and 100 mM indomethacin for
72 hours. Then the medium was replaced with maintenance
medium containing 10 mg/ml insulin in DMEM and 10% FCS
and cultured for an additional 24 hours. This 96-hour treatment
cycle was repeated three times, followed by culture for several
additional days in adipogenic maintenance medium until 21
days. Negative control wells were maintained in DMEM/F12
supplemented with 10% FCS for the duration of the assay. To
visualize the lipid-rich vacuoles in the cells, cells were stained with
oil red o. Briefly, cell layers were fixed with 4% formaldehyde and
stained with oil red o for 15 minutes. Hematoxylin was used for
nuclear staining. Finally, the cultures were extensively washed
with water to remove excess stain, and were observed by mic-
roscopic inspection (Leica, Germany). To quantify adipogenic
differentiation by morphology, the differentiation value (DV)
method was adopted as previously described [25]. Briefly, 105
high power fields (15 random fields from one source,
2006magnification ) from 7 biological sources of BM-MSCs and
Figure 4. Cell cycle analysis of BM-MSCs and CESCs. Representative cell cycle graphs of BM-MSCs (A) and CESCs (B) were showed. The
percentage of cells in each phase of the cell cycle was analyzed by flow cytometry (C). There were no significant differences in all cell cycle phases
(G0/G1, S and G2/M) between BM-MSCs and CESCs. Data from cells derived from 7 different patients (mean 6 SD).
doi:10.1371/journal.pone.0026285.g004
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The DV was determined by dividing the lipid droplet area by the
number of nuclei.
Quantitative Assay of Adipogenic Capacity
To quantify the adipogenic capacity of BM-MSCs and CESCs,
quantitative adipogenesis kit (Genmed, USA) was used. This kit
used a colorimetric assay kit that was based on oil red o staining
the lipid-rich vacuoles red. The optical density (OD) increased
with the appearance of more red lipid-rich vacuoles in the cells.
The OD values indicated the adipogenic capacity. The procedure
was performed strictly according to the manufacturer’s instruction.
Briefly, 1.5610
4 BM-MSCs and CESCs were seeded in each well
of a 96-well plate. After incubated at 37uC for 90 minutes,
adipogenic induction medium was added into each well and
cultured for 1, 2 or 3 weeks. At each induction time point, the wells
were cleaned, fixed, dyed with oil red o, lysed on a shaking table at
50 reverse per minute at 37uC for 30 minutes according to the
instruction. The density of the extracted dye was evaluated at
490 nm in a BioRad reader. The blank 96-well plate was set as the
zero level.
(3). Chondrogenic Induction. Cells were incubated using
the micromass culture method. Micromass cultures were generated
by adding 20 ml droplets of cell solution (1.0610
7cells/ml) in the
center of multi-well plate wells. After cultivating the micromass
cultures for 2 hours under high humidity conditions, the
chondrogenic medium, which contained low-glucose DMEM,
supplemented with 10 ng/ml transforming growth factor (TGF)-
b3,1 0
27 M dexamethasone, 50 mg/ml ascorbate-2-phosphate,
40 mg/ml proline, 100 mg/ml pyruvate, and 1:100 diluted
ITS+Premix, was added to the culture and incubated up to 3
weeks. The medium was changed twice per week.
Quantitative Assay of Alcian Blue Intensity
The alcian blue intensity assay was performed as described
previously [26]. Briefly, both cells were cultured in the micromass
culture for 1, 2 or 3 weeks. After each time point, the cells were
rinsed twice with PBS, fixed with 10% neutral buffered formalin
(pH 7.4) including 1% CPC for 15 minutes at room temperature,
then washed with PBS, and covered with 1% alcian blue 8 GS
(pH 1.0 ) in 0.1 M HCl for 1 hour. The cultures were rinsed with
50 mM Tris-HCl (pH 7.4) and incubated with 300 mL solution
that containing 4 M guanidine–HCl, 50 mM Tris–HCl, 0.1%
CHAPS( pH 7.4) for 3 hours at room temperature. The optical
density of the extracted dye was evaluated at 595 nm in a
spectrophotometer.
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR)
To evaluate the expression of the genes responsible for stem
cells (NANOG, OCT4 and SOX2), RT-PCR was used. Total RNA
was extracted from BM-MSCs and CESCs using the RNeasy kit
(Qiagen GmbH, Germany) according to the manufacturer’s
instructions. Isolated RNA was treated with RNase-free DNase
(QIAGEN GmbH) before being reverse transcribed into cDNA.
Total RNA was measured by a spectrophotometer (Beckman,
Fullerton, CA) at 260 nm and 280 nm. The RNA (1 mg) was
reverse transcribed with an oligo (dT) primer using the
ThermoScriptTM RT-PCR system (Invitrogen, USA) for cDNA
synthesis. For RT-PCR, 1 mL of cDNA template was used for
Figure 5. Immunophenotypic profile of BM-MSCs (A) and CESCs (B) analyzed by FACS. The green lines represent the fluorescence
intensity of cells stained with the indicated antibodies and the black lines represent the negative control cells, which were stained with a non-
immunoreactive isotype control antibody.
doi:10.1371/journal.pone.0026285.g005
Table 3. The average values of surface immunophenotypes
from 7 donors.
Markers BM-MSCs mean (SD) CESCs mean (SD)
CD73 97.34 (2.12) 96.10 (2.07)
CD90 98.45 (1.42) 98.01 (1.13)
CD44 98.87 (2.04) 96.63 (2.43)
Stro-1 98.37 (1.18) 98.04 (1.61)
CD105 97.78(2.36) 82.02(9.41)*
CD166 95.86(2.52) 45.63(12.04)*
CD133 4.63(2.73) 6.02(3.74)
CD14 0.46(0.23) 0.33(0.19)
CD34 0.65(0.18) 0.56(0.11)
CD19 0.72(0.23) 0.81(0.20)
CD45 1.12(0.67) 0.67(0.21)
HLA-DR 0.89(0.48) 0.95(0.64)
*indicated p,0.05.
doi:10.1371/journal.pone.0026285.t003
Figure 6. Stem cell gene expression. Stem cell genes (OCT-4,
NANOG, and SOX-2) were expressed both in BM-MSCs and CESCs.
doi:10.1371/journal.pone.0026285.g006
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polymerase. Stem cell gene primers were designed and synthe-
sized as shown in Table 2. b-actin was used to normalize the
reactions.
Real-time Quantitative Reverse Transcriptase Polymerase
Chain Reaction (qPCR) Assay
To compare the mRNA levels of osteogenic, adipogenic-, and
chondrogenic- specific genes of BM-MSCs and CESCs after a 3-
week induction, qPCR was used. Total RNA extraction was
performed as described above. The RT reaction (2.0 mL) was
amplified in quadruplex by real-time PCR (ABI PRISM 7000) in a
final volume of 25 mL, using SYBR Green Master Mix reagent at
a final concentration of 16(Applied Biosystems, Foster City, CA).
Osteogenic-, adipogenic- and chondrogenic- specific genes for
qPCR were shown in Table 2. b-actin was used to normalize the
reactions. For each cDNA sample, the threshold cycle (Ct) value of
each target sequence was subtracted from the Ct value of the
reference gene. The expression level of each target gene was
calculated as 2
DCt. Each sample was assessed three times for each
gene. Three samples were randomly selected.
Immunohistochemical Staining
The appropriate micromass pellet slides were deparaffinized
and pretreated by heating in citrate buffer at 95–100uC for
10 minutes. The pretreated samples (5 mm thick) were then fixed
in 4% paraformaldehyde, quenched with 10% H2O2 in metha-
nol for 20 minutes, blocked with 5% normal goat serum and
incubated with the following primary monoclonal antibodies in a
humidified chamber at room temperature for 1 hour: type II
collagen (mouse, 1:100, Sigma, USA) and aggrecan (mouse, 1:100,
Sigma, USA). After washing with PBS, the cells were incubated
with biotinylated anti-mouse IgG antibody (1:100, Sigma, USA)
in a humidified chamber at room temperature for 30 minutes.
Finally, a 3, 39-diaminobenzidine tetrahydrochloride (DAB) sub-
strate solution was used to reveal the color of antibody staining in
the presence of H2O2. The slides were rinsed in distilled water,
dehydrated through graded alcohol, and mounted with p-xylene-
bis-pyridinium bromide (DPX). The slides were examined using a
light microscopy (Leica, Germany).
Western Blot Assay of Type II Collagen and Aggrecan
Micromass pellets from the BM-MSCs and CESCs after 3
weeks in the chondrogenic induction medium were used for
western blot analysis. The samples were incubated with an
extraction solution containing 1 ml 4 M guanidine chloride
(GuCl), 0.1 M -6-aminohexanoic acid, 20 mM -benzamidine
hydrochloride, 10 mM -EDTA, 5 mM -N-ethylmaleimide and
0.5 mM phenylmethanesulfonyl fluoride, pH 5.0 at 4uC for
3 hours. GuCl extracted dialysate was resuspended in 50 ml of
sample buffer and analyzed by electrophoresis on a 6% (w/v)
SDS-PAGE gels. Equal amounts of protein per lane (50 mg) were
loaded and separated by electrophoresis. Protein was transferred
to a polyvinylidene fluoride (PVDF) membrane by electroblotting.
Rinse the membrane in water and block the blotted membrane in
freshly prepared PBS containing nonfat dry milk (5%) for
Figure 7. Osteogenic differentiation of BM-MSCs and CESCs
stained with alizarin red after 3 weeks. BM-MSCs and CESCs
treated with growth culture medium alone (A: BM-MSCs, B: CESCs)
showed minimally alizarin red positive staining, and cells treated with
osteogenic medium (C: BM-MSCs, D: CESCs) showed mineral deposition
around the cells to form nodular aggregates after 3 weeks.
Bar=100 mm.
doi:10.1371/journal.pone.0026285.g007
Figure 8. Quantitative analysis of mineral deposition and ALP activity of both cell types in the osteogenic medium. A. results of
mineral deposition B. results of ALP activity. Data from cells derived from 7 different patients (mean 6 SD). * indicated p,0.05.
doi:10.1371/journal.pone.0026285.g008
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membrane was incubated with the human type II collagen (mouse,
130 kD, 1:1000, Sigma, USA) and aggrecan (mouse, 250 kD,
1:1000, Sigma, USA) antibodies overnight at 4uC with agitation.
After washed the membrane three times with PBS, the secondary
goat anti-mouse horseradish peroxidase (HRP)-conjugated anti-
body was added and incubated overnight at 4uC with agitation.
Subsequently, the blots were washed 5 times with PBS containing
0.05% Tween 20 and the signal of bound antibodies was
developed by enhanced chemiluminescence.
Histochemical Staining
Alizarin red staining. To identify the mineral deposits by
alizarin red staining, the cells in culture medium, were fixed in
70% ethanol for 10 minutes and stained with 0.5% alizarin red
(pH 4.1) for 10 minutes.
Oil red o staining. To localize lipid droplets, cell layers were
fixed in 4% paraformaldehyde for 30 minutes and incubated in oil
red o solution for 15 minutes. Finally, the cultures were extensively
washed with water to remove excess stain, and microscopically
observed.
Alcian blue staining. To visualize the deposition of sulfated
glycosaminoglycans, the slides were incubated with 1% alcian blue
8GX in 0.1 M HCl overnight. Finally, cultures were washed
extensively with distilled water and photographed.
Statistical Analysis
The absorbance, percentage of cell cycle phase, immunophe-
notype and gene expression level was reported as mean 6 SD
(standard deviation). The histological and immunohistochemical
data were qualitatively described. Representative images were
shown. Quantifiable data comparing the BM-MSCs and CESCs
were analyzed using Student’s t-tests. All of the data analyses were
performed using SPSS version 10.0. p,0.05 was regarded as
statistically significant.
Results
Histomorphology of Degenerated Human CEP Tissues
The CEP was white and translucent after being cleaned under
the dissecting microscope (Figure 1A). The extracellular matrix
(ECM) of CEP tissues was homogeneous and contained round-
shaped chondrocytes distributed into different layers (Figure 1B).
No vascular or fat tissues were observed in any of the CEP tissues.
Morphology and Cell Proliferation Capacity of BM-MSCs
and CESCs
To screen the proliferative cells, agarose culture was used. P1
CEP-derived cells were loaded into the low melting agarose
culture, and all of the cells were dispersed in the agarose and kept
in monoplast suspension (Figure 2A). After being cultured in
agarose for six weeks, some of the seeded cells formed cell clusters
with diameters greater than 50 mm, and some cells had not divided
and were still in the monoplast state (Figure 2B). We chose the cell
clones with a diameter greater than 50 mm and subcultured them
in multi-well plates for expansion. Mononuclear cells (5610
5 to
2.5610
6) from a 5-ml to 10-ml iliac crest aspiration were acquired
from the subjects and were cultured in flasks. When P3 cells
reached 90% confluence, the BM-MSCs and CESCs exhibited a
homogeneous fibroblast-like morphology with a spindle shaped
appearance while in culture as shown in Figure 2. Regarding the
proliferation capacity, both stem cell types exhibited similar
growth tendencies. The OD value increased from day 1 to day 7
and reached a plateau from day 7 to day 9. Although the OD
value of BM-MSCs was slightly higher than that of the CESCs at
each time point, the differences were not significant (p.0.05,
Figure 3).
Cell Cycle of BM-MSCs and CESCs
Representative graphs of cell cycle for both stem cells were
shown in Figure 4. A cell cycle analysis by measuring the DNA
content revealed that a small population of the cells were engaged
in proliferation (S1+G2+M,20%). More than 80% of the BM-
MSCs and CESCs were in the G0/G1 phase (84.46% vs. 85.35%),
and there were no significant differences in the percentage of cells
in the G0/G1 phase between the BM-MSCs and CESCs. No
significant differences were observed in percentage of cells in the
G2/M phase (8.66% vs. 7.39%) or S phase (6.91% vs. 8.25%)
between the BM-MSCs and CESCs (Figure 4C).
Figure 9. The mRNA levels of osteogenic genes. There were
higher expression levels of OC and ALP after 3-week induction of CESCs
compared with that of BM-MSCs. There was no significant difference of
RUNX2 expression between BM-MSCs and CESCs. * indicated p,0.05.
doi:10.1371/journal.pone.0026285.g009
Figure 10. BM-MSCs and CESCs stained with oil red o after 3
week induction. BM-MSCs and CESCs were treated with growth
culture medium alone (A, B) or adipogenic induction medium (C, D) and
stained with oil red. Bar=50 mm.
doi:10.1371/journal.pone.0026285.g010
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The antigenic phenotype of BM-MSCs and CESCs was
checked by flow cytometric analysis (Figure 5). CESCs were
positive for many stem cell markers common to BM-MSCs,
including CD105, CD73, CD90, CD44, CD166 and Stro-1, and
they were slightly positive for CD133. However, the percentages of
CD105- and CD166- positive cells were significantly lower in the
CESCs than in the BM-MSCs. The BM-MSCs and CESCs were
negative for the pan-monocytic antigen CD14, the hematopoietic
stem cell marker CD34, the pan-B-cell marker CD19, the pan-
hematopoietic marker CD45, and the class 2 HLA antigen HLA-
DR (Figure 5). The mean surface immunophenotype expression
values and SD from seven donors were summarized in Table 3.
Stem Cell Gene Analysis
OCT-4, NANOG, and SOX-2 were genes that were commonly
expressed in stem cells. Passage 3 cells were chosen to identify the
expression of these genes. Compared to BM-MSCs, CESCs
showed comparable gene expression (Figure 6).
Osteogenic Differentiation
The BM-MSCs and CESCs cultured in the growth medium for
3 weeks were negative for alizarin red (Figures 7A, B). Osteogenic
differentiation was confirmed by the deposition of an alizarin red
positive mineralized matrix (Figures 7C, D). From the morphol-
ogy, the mineralized nodules from CESCs were larger and stained
more intensely, indicating more extensive calcium deposition.
Absorption of the dye at 562 nm revealed more alizarin red
positive mineralized matrices from CESCs than BM-MSCs
at week 1, 2, and 3, but no significant difference at week 4
(Figure 8A). The ALP activity results showed that the OD values of
CESCs were greater than the OD values of BM-MSCs during the
first three weeks (p,0.05), but the OD values for both decreased in
the fourth week (Figure 8B). According to qPCR, no significant
difference was observed in the expression of RUNX-2 between the
two groups. However, the expressions of ALP and OC were higher
in CESCs (p,0.05, Figure 9). These results indicated that CESCs
were superior in osteogenesis than BM-MSCs.
Adipogenic Differentiation
T h ep r e s e n c eo fl i p i d - r i c hv a c u o l e ss t a i n e dw i t ho i lr e dOw a su s e d
to evaluate adipogenic induction. Both cell types exhibited
intracellular lipid vacuoles after 3 weeks of adipogenic induction,
but they were not detected in the growth medium (Figure 10). We
analyzed the DV results using IPP 6.0 at each time point and found
that lipid droplets gradually accumulated within both cell types, while
no significant difference was found between them at any time point
(p.0.05, Figure 11A). For quantitative adipogenic capacity analysis,
the OD values at 490 nm showed that no significant difference
existed for the adipogenic capacity between the two groups at any
induction time point (Figure 11B). Regarding the expression of
adipogenic genes (PPAR-2, LPP and APP), no significant differences
were observed after 3 weeks of induction (Figure 12).
Chondrogenic Differentiation
For in vitro chondrogenesis, a micromass pellet culture was
performed to evaluate the chondrogenic potential. BM-MSCs and
Figure 11. Adipogenesis of BM-MSCs and CESCs. A. Differentiation value (DV), analyzed using IPP 6.0, showed that there was no significance in
DV at corresponding time point. B. Adipogenic capacity, measured using adipogenic quantitative kit at 490 nm, showed that there was no
significance in adipogenic capacity at each time point. Data from cells derived from 7 different patients (mean 6 SD).
doi:10.1371/journal.pone.0026285.g011
Figure 12. The mRNA levels of adipogenic genes after 3-week
induction. There was no significant difference for all the three
adipogenic genes (PPAR-2, LPP and APP) between BM-MSCs and CESCs.
doi:10.1371/journal.pone.0026285.g012
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and they floated freely in the chondrogenic induction suspension
culture medium. During chondrogenesis, the pellet size increased,
and the pellets derived from CESCs were larger and heavier than
the pellets from BM-MSCs at the corresponding induction time
(Figure 13). Histologically, the cell pellets derived from the BM-
MSCs and CESCs exhibited intense staining of sulfated proteo-
glycans after 3 weeks of induction (Figure 14). Immunohistochem-
ical staining showed high accumulation of aggrecan and collagen
II proteins in both pellets (Figure 14). The alcian blue staining
intensity of the pellets derived from CESCs was higher than that of
BM-MSCs at the corresponding time point (Figure 15). For the
chondrogenic genes, the mRNA expression levels of Col II and
aggrecan in CESCs were higher but no significant difference for
SOX9 was observed between the cell types (Figure 16A). Western
blot analysis indicated that both Col II and aggrecan protein levels
were higher in CESCs, which was in accordance with the qPCR
results (Figure 16B). All of these results demonstrated that CESCs
had a greater chondrogenesis potential than BM-MSCs.
Discussion
In this study, we have successfully isolated a universal cell
population with stem cell characteristics from degenerated human
intervertebral disc CEP. This report is the first to isolate and
characterize human CESCs in vitro. We have compared the
morphology, proliferation potential, cell cycle, immunophenotype,
stem cell gene expressions and differentiation ability of CESCs
with those of BM-MSCs from the same subjects. The results reveal
that CESCs are superior in terms of the osteogenic and
chondrogenic capacity in vitro. This result demonstrates that
CESCs may be a new cell source that may be more suitable for
bone and cartilage repair.
The gross and histological morphology of the CEP showed that
there were no vascular or fat tissues in the retrieved samples
ensuring that other potential sources of stem cells were excluded.
Agarose suspension culture is a chondrocyte selective culture
system, in which chondrocytes are the only cell type to survive
apart from tumor cells [27]. Thornemo cultured chondrocytes in
Figure 13. Time course for the synthesis of cartilage by BM-MSCs and CESCs cultured in micromass culture system. A. Macro pictures
of differentiating aggregates from BM-MSCs and CESCs at week 1, 2 and 3. B. Wet weight of cell aggregates at week 1, 2 and 3. Data from cells
derived from 7 different patients (mean 6 SD, * p,0.05).
doi:10.1371/journal.pone.0026285.g013
Figure 14. Histology of mcromass pellets derived from BM-MSCs and CESCs in the chondrogenic medium after 3 weeks. Pellets
derived from BM-MSCs (A, B) and CESCs (C, D) stained with alcian blue (A, C) and toluidine blue (B, D). Immunohistochemistry for aggrecan (E, G) and
type II collagen (F, H) in the pellets derived from BM-MSCs (E, F) and CESCs (G, H). Bar=100 mm.
doi:10.1371/journal.pone.0026285.g014
Stem Cells in Degenerated Human Cartilage Endplate
PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e26285agarose for six weeks and identified cell clusters with diameters
greater than 50 mm. Furthermore, parts of these cell clusters had
multi-directional differentiation capacity [22]. Using an agarose
culture, we excluded the existence of cell types other than
chondrocytes and found that some CEP-derived cells formed cell
clusters with diameters larger than 50 mm. These cell clusters were
chosen and expanded in vitro. Further results demonstrated that
CESCs shared similar characteristics with BM-MSCs. First,
CESCs were enriched by allowing the cells to adhere to a plastic
tissue culture flask. The adherent cells exhibited morphology and
proliferation capacity similar to those of BM-MSCs. Second, the
CESCs were positive for many stem cell markers (e.g. CD105,
CD73, CD90, CD44, CD166, Stro-1 and CD133), and negative
for the pan-monocytic antigen CD14, the hematopoietic stem cell
marker CD34, the pan-B-cell marker CD19, the pan-hematopoi-
etic marker CD45, and the class 2 HLA antigen HLA-DR. Finally,
the CESCs exhibited differentiation potential into osteoblasts,
adipocytes and chondrocytes under the appropriate induction
conditions. According to the criteria used to define MSCs stated
by the International Society for Cellular Therapy (ISCT) [28], our
results fulfill the majority of the ISCT requirements for MSCs
definition: in vitro adherence to plastic surfaces, immunophenotypic
profile and multilineage differentiation capacity into osteogenic,
adipogenic and chondrogenic lineages. Additionally, CESCs and
BM-MSCs share the same characteristics of cell cycle and stem cell
genes. Reems et al. reported that the vast majority of primitive
progenitorcellsresided inthe G0/G1phase.Thusthepercentagein
the G0/G1 phase is more relevant to the stemness of cells [29]. In
our study, the cell cycle results showed that the vast majority of both
cell types were in the G0/G1phase and that less than 15% of the
cellswereintheS and G2+M phases. OCT-4,NANOG, and SOX-
2, are transcription factors that play a central role in the regulation
of pluripotency and self-renewal. These three transcription factors
areexpressedat high levels inpluripotent cellsand areconsideredto
bemarkersofprimitivestemcells[30].Expressionofthe abovestem
cell genes in our study provided more evidence for the existence of
stem cells in the degenerated CEP.
Although CESCs share many characteristics with the BM-
MSCs, other studies have indicated that variations existed among
tissue sources [25,31]. Our results are also in accordance with
those findings. For the immunophenotypic profiles, the percent-
ages of CD105- and CD166-positive cells in CESCs were lower
compared to BM-MSCs. Three causes might explain this finding.
First, variability in the epitope profile reflects the original tissue
sources [32]. Second,digestion, isolation, different culturing
conditions, or expansion in vitro may have resulted in changes to
their original profiles [33]. Finally, these changes may be related to
the function of the cell’s origin. CD105 has been described as
being related to hematopoiesis and cell migiration. CD166 is
involved in homophilic and heterophilic adhesive interactions
between early hematopoietic progenitors and associated stromal
cells in primary blood-forming organs [34,35]. Thus, these two
adhesion molecules may be more important for BM-MSCs for
homing capacity in the bone marrow.
Furthermore, our study indicated that the CESCs exhibited a
higher osteogenic potential compared to the BM-MSCs. ALP
activity is considered to be associated with osteoblastic differen-
tiation, and it is thought to initially increase and then decrease
when mineralization is well progressed [36,37]. Our results were
also in accordance with this model. For either BM-MSCs or
CESCs, the mineralization extent gradually increased during the
observation period. For both cell types, ALP activity increased in
the first three weeks and then decreased in the fourth week. The
qPCR results also demonstrated that CESCs had higher ALP
expression levels, which is recognized as an early osteoblastic
marker [38], and more osteocalcin, which is usually used as a
marker of mature osteoblasts [39]. These results indicated that the
osteogenic capacity of CESCs was superior in the early and late
osteogenic stages.
No significant difference was detected regarding the adipogenic
capacity of BM-MSCs and CESCs. However, the high DV
variations observed in the BM-MSCs should benoted. This
phenomenon may be a consequence of the heterogeneous cell
population of the BM-MSCs [25]. In contrast, the CESCs used in
the present study were derived from solid tissue and the cells were
more homogeneous, which resulted in small DV variations.
Finally, we have quantitatively evaluated the chondrogenic
potential of BM-MSCs and CESCs. Our results demonstrated that
CESCs have a better chondrogenic ability than BM-MSCs
according to the wet weight of micromass pellets, the dye
absorbance of alcian blue and qPCR. Stable radioactivity per
DNA in cells prelabeled with
3H-thymidine during in vitro
chondrogenesis of MSCs indicated that there was little prolifer-
ation in the pellets. Thus, the pellet size was increased by the
production of the extracellular matrix, not by the proliferation of
the cells [40]. Therefore, the size or weight is considered to be a
factor used to compare the chondrogenic potential of different
stem cells [20]. For qPCR, the much stronger matrix production
(collagen II and aggrecan) was not accompanied by an increase in
Figure 15. Alcian blue staining intensity of the micromass
pellets from BM-MSCs and CESCs at corresponding time
(week). A. Macro pictures of aggregates stained with alcian blue at
week 1, 2 and 3. B. The absorbance of CESCs pellets was higher than
that of BM-MSCs at each time point. * indicated p,0.05.
doi:10.1371/journal.pone.0026285.g015
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stimulates the expression of extracellular matrix components, such
as collagen II and aggrecan [41,42]. Some authors believed that low
SOX-9 expression levels were already sufficient to support matrix
production [43,44]. In addition, the samples selected in the study
were degenerated, and some authors believed that the expression of
SOX-9 decreased with increasing IVD degeneration grade [45].
Despite the strength of these findings, an inevitable problem must
be addressed in our findings. The samples used in our study were
degenerated; therefore, the biochemical composition within the
degenerated CEP must have changed to some extent. The
interactions between stem cells and their surrounding niche are
essential to modulate cell morphology, phenotype and function,
including in vitro differentiation [46,47]. Therefore, the effect of
biochemical changes in degenerated CEP on CESCs remains to be
elucidated. Furthermore, the degenerated CEP might involve a
substantial amount of inflammation factors and cytokines. The effects
these mediators might have on the stem cells within the degenerated
CEPare unknown. Whether the differenceofimmunophenotype and
in vitro trilineage differentiation capacity between BM-MSCs and
CESCs are related to the above causes needs to be identified.
In conclusion, this paper is the first report on the presence of
stem cells in degenerated human intervertebral disc CEP, and
we compared CESCs to BM-MSCs. Based on our results, the
investigation into the characteristics of CESCs may improve our
understanding of IVD pathophysiology and the degeneration
process, and it would provide cell candidates for cell-based
regenerative medicine and tissue engineering. In our future
studies, we will investigate whether these cells can maintain their
multipotency in vivo and in bioscaffolds, and whether they can be
applied in tissue-engineering and regenerative medicine.
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Figure 16. The assays of chondrogenesis derived from BM-MSCs and CESCs after 3 week culturing. A. The mRNA expression levels.
There was a higher mRNA expression level of Col II and Agg in CESCs after 3 week induction (p,0.05). For SOX9, no significant difference was found.
B. Western blots for Col II and aggrecan. Higher Col II and aggrecan protein levels could be found in CESCs. * indicated p,0.05.
doi:10.1371/journal.pone.0026285.g016
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